nodes	percent_of_prediction	percent_of_DWPC	metapath
Mycophenolate mofetil—ABCC2—esophageal cancer	0.25	0.731	CbGaD
Mycophenolate mofetil—CES1—Capecitabine—esophageal cancer	0.176	0.441	CbGbCtD
Mycophenolate mofetil—ABCB1—esophageal cancer	0.092	0.269	CbGaD
Mycophenolate mofetil—SLCO1B3—Methotrexate—esophageal cancer	0.0339	0.0852	CbGbCtD
Mycophenolate mofetil—ABCC2—Carboplatin—esophageal cancer	0.0313	0.0786	CbGbCtD
Mycophenolate mofetil—ABCG2—Carboplatin—esophageal cancer	0.0283	0.071	CbGbCtD
Mycophenolate mofetil—ABCC2—Cisplatin—esophageal cancer	0.0267	0.0671	CbGbCtD
Mycophenolate mofetil—ABCG2—Cisplatin—esophageal cancer	0.0242	0.0607	CbGbCtD
Mycophenolate mofetil—SLCO1B1—Methotrexate—esophageal cancer	0.0198	0.0496	CbGbCtD
Mycophenolate mofetil—ABCC2—Methotrexate—esophageal cancer	0.0174	0.0436	CbGbCtD
Mycophenolate mofetil—ABCG2—Methotrexate—esophageal cancer	0.0157	0.0394	CbGbCtD
Mycophenolate mofetil—ALB—Methotrexate—esophageal cancer	0.0108	0.0272	CbGbCtD
Mycophenolate mofetil—ABCB1—Cisplatin—esophageal cancer	0.00872	0.0219	CbGbCtD
Mycophenolate mofetil—ABCB1—Methotrexate—esophageal cancer	0.00566	0.0142	CbGbCtD
Mycophenolate mofetil—CES1—larynx—esophageal cancer	0.00512	0.124	CbGeAlD
Mycophenolate mofetil—UGT1A7—digestive system—esophageal cancer	0.00252	0.0612	CbGeAlD
Mycophenolate mofetil—UGT1A10—digestive system—esophageal cancer	0.00211	0.0512	CbGeAlD
Mycophenolate mofetil—UGT1A6—digestive system—esophageal cancer	0.00196	0.0476	CbGeAlD
Mycophenolate mofetil—IMPDH2—neck—esophageal cancer	0.00181	0.044	CbGeAlD
Mycophenolate mofetil—UGT1A8—digestive system—esophageal cancer	0.00167	0.0405	CbGeAlD
Mycophenolate mofetil—CES1—neck—esophageal cancer	0.00136	0.0329	CbGeAlD
Mycophenolate mofetil—IMPDH2—bronchus—esophageal cancer	0.00121	0.0295	CbGeAlD
Mycophenolate mofetil—IMPDH1—bronchus—esophageal cancer	0.00121	0.0293	CbGeAlD
Mycophenolate mofetil—IMPDH2—smooth muscle tissue—esophageal cancer	0.00119	0.0289	CbGeAlD
Mycophenolate mofetil—IMPDH1—smooth muscle tissue—esophageal cancer	0.00118	0.0287	CbGeAlD
Mycophenolate mofetil—CES2—bronchus—esophageal cancer	0.0011	0.0268	CbGeAlD
Mycophenolate mofetil—IMPDH2—trachea—esophageal cancer	0.00109	0.0265	CbGeAlD
Mycophenolate mofetil—IMPDH1—trachea—esophageal cancer	0.00108	0.0263	CbGeAlD
Mycophenolate mofetil—CES2—smooth muscle tissue—esophageal cancer	0.00108	0.0262	CbGeAlD
Mycophenolate mofetil—UGT1A9—digestive system—esophageal cancer	0.00106	0.0257	CbGeAlD
Mycophenolate mofetil—CES2—trachea—esophageal cancer	0.000991	0.0241	CbGeAlD
Mycophenolate mofetil—IMPDH2—digestive system—esophageal cancer	0.000938	0.0228	CbGeAlD
Mycophenolate mofetil—SLCO1B3—lung—esophageal cancer	0.000871	0.0212	CbGeAlD
Mycophenolate mofetil—CES2—digestive system—esophageal cancer	0.000853	0.0207	CbGeAlD
Mycophenolate mofetil—UGT2B7—digestive system—esophageal cancer	0.000853	0.0207	CbGeAlD
Mycophenolate mofetil—IMPDH2—lung—esophageal cancer	0.000784	0.019	CbGeAlD
Mycophenolate mofetil—IMPDH1—lung—esophageal cancer	0.000779	0.0189	CbGeAlD
Mycophenolate mofetil—UGT1A1—digestive system—esophageal cancer	0.000725	0.0176	CbGeAlD
Mycophenolate mofetil—CES2—lung—esophageal cancer	0.000712	0.0173	CbGeAlD
Mycophenolate mofetil—CES1—digestive system—esophageal cancer	0.000702	0.0171	CbGeAlD
Mycophenolate mofetil—SLCO1B1—digestive system—esophageal cancer	0.000603	0.0147	CbGeAlD
Mycophenolate mofetil—CES1—lung—esophageal cancer	0.000587	0.0142	CbGeAlD
Mycophenolate mofetil—IMPDH2—lymph node—esophageal cancer	0.000536	0.013	CbGeAlD
Mycophenolate mofetil—IMPDH1—lymph node—esophageal cancer	0.000533	0.0129	CbGeAlD
Mycophenolate mofetil—CES2—lymph node—esophageal cancer	0.000487	0.0118	CbGeAlD
Mycophenolate mofetil—ABCC2—digestive system—esophageal cancer	0.000457	0.0111	CbGeAlD
Mycophenolate mofetil—CES1—lymph node—esophageal cancer	0.000401	0.00974	CbGeAlD
Mycophenolate mofetil—CYP3A5—digestive system—esophageal cancer	0.00031	0.00752	CbGeAlD
Mycophenolate mofetil—ALB—lymph node—esophageal cancer	0.000279	0.00677	CbGeAlD
Mycophenolate mofetil—ABCG2—lung—esophageal cancer	0.000279	0.00677	CbGeAlD
Mycophenolate mofetil—ABCC2—lymph node—esophageal cancer	0.000261	0.00635	CbGeAlD
Mycophenolate mofetil—CYP3A5—lung—esophageal cancer	0.000259	0.00628	CbGeAlD
Mycophenolate mofetil—CYP3A4—digestive system—esophageal cancer	0.000232	0.00564	CbGeAlD
Mycophenolate mofetil—ABCB1—epithelium—esophageal cancer	0.000216	0.00525	CbGeAlD
Mycophenolate mofetil—ABCB1—trachea—esophageal cancer	0.000191	0.00464	CbGeAlD
Mycophenolate mofetil—ABCG2—lymph node—esophageal cancer	0.000191	0.00463	CbGeAlD
Mycophenolate mofetil—ABCB1—digestive system—esophageal cancer	0.000164	0.004	CbGeAlD
Mycophenolate mofetil—Pulmonary oedema—Methotrexate—esophageal cancer	0.000159	0.00155	CcSEcCtD
Mycophenolate mofetil—Hypokalaemia—Capecitabine—esophageal cancer	0.000159	0.00155	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Cisplatin—esophageal cancer	0.000158	0.00154	CcSEcCtD
Mycophenolate mofetil—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000157	0.00153	CcSEcCtD
Mycophenolate mofetil—Sepsis—Methotrexate—esophageal cancer	0.000155	0.00151	CcSEcCtD
Mycophenolate mofetil—Gastritis—Capecitabine—esophageal cancer	0.000154	0.00151	CcSEcCtD
Mycophenolate mofetil—Muscular weakness—Capecitabine—esophageal cancer	0.000154	0.0015	CcSEcCtD
Mycophenolate mofetil—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.000154	0.0015	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Cisplatin—esophageal cancer	0.000153	0.00149	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Cisplatin—esophageal cancer	0.000153	0.00149	CcSEcCtD
Mycophenolate mofetil—Lymphadenopathy—Methotrexate—esophageal cancer	0.000152	0.00148	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Cisplatin—esophageal cancer	0.000152	0.00148	CcSEcCtD
Mycophenolate mofetil—Abdominal distension—Capecitabine—esophageal cancer	0.000152	0.00148	CcSEcCtD
Mycophenolate mofetil—Influenza—Capecitabine—esophageal cancer	0.000151	0.00147	CcSEcCtD
Mycophenolate mofetil—Dysphagia—Capecitabine—esophageal cancer	0.000151	0.00147	CcSEcCtD
Mycophenolate mofetil—Asthma—Capecitabine—esophageal cancer	0.000151	0.00147	CcSEcCtD
Mycophenolate mofetil—Thrombophlebitis—Methotrexate—esophageal cancer	0.00015	0.00146	CcSEcCtD
Mycophenolate mofetil—Diabetes mellitus—Methotrexate—esophageal cancer	0.000149	0.00146	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Cisplatin—esophageal cancer	0.000148	0.00144	CcSEcCtD
Mycophenolate mofetil—Angina pectoris—Capecitabine—esophageal cancer	0.000147	0.00143	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Cisplatin—esophageal cancer	0.000146	0.00143	CcSEcCtD
Mycophenolate mofetil—Bronchitis—Capecitabine—esophageal cancer	0.000145	0.00141	CcSEcCtD
Mycophenolate mofetil—Alopecia—Cisplatin—esophageal cancer	0.000145	0.00141	CcSEcCtD
Mycophenolate mofetil—Hepatic failure—Methotrexate—esophageal cancer	0.000144	0.00141	CcSEcCtD
Mycophenolate mofetil—Pancytopenia—Capecitabine—esophageal cancer	0.000143	0.0014	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Cisplatin—esophageal cancer	0.000143	0.00139	CcSEcCtD
Mycophenolate mofetil—Dysuria—Capecitabine—esophageal cancer	0.000141	0.00137	CcSEcCtD
Mycophenolate mofetil—Neutropenia—Capecitabine—esophageal cancer	0.000141	0.00137	CcSEcCtD
Mycophenolate mofetil—Renal failure acute—Methotrexate—esophageal cancer	0.000141	0.00137	CcSEcCtD
Mycophenolate mofetil—Flatulence—Cisplatin—esophageal cancer	0.00014	0.00137	CcSEcCtD
Mycophenolate mofetil—ABCB1—lung—esophageal cancer	0.000137	0.00334	CbGeAlD
Mycophenolate mofetil—Weight increased—Capecitabine—esophageal cancer	0.000137	0.00134	CcSEcCtD
Mycophenolate mofetil—Visual disturbance—Methotrexate—esophageal cancer	0.000137	0.00134	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Cisplatin—esophageal cancer	0.000137	0.00134	CcSEcCtD
Mycophenolate mofetil—Weight decreased—Capecitabine—esophageal cancer	0.000136	0.00133	CcSEcCtD
Mycophenolate mofetil—Hyperglycaemia—Capecitabine—esophageal cancer	0.000136	0.00133	CcSEcCtD
Mycophenolate mofetil—Pneumonia—Capecitabine—esophageal cancer	0.000135	0.00132	CcSEcCtD
Mycophenolate mofetil—Infestation—Capecitabine—esophageal cancer	0.000134	0.00131	CcSEcCtD
Mycophenolate mofetil—Infestation NOS—Capecitabine—esophageal cancer	0.000134	0.00131	CcSEcCtD
Mycophenolate mofetil—Depression—Capecitabine—esophageal cancer	0.000134	0.00131	CcSEcCtD
Mycophenolate mofetil—Tremor—Cisplatin—esophageal cancer	0.000134	0.0013	CcSEcCtD
Mycophenolate mofetil—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000133	0.00129	CcSEcCtD
Mycophenolate mofetil—Cerebrovascular accident—Methotrexate—esophageal cancer	0.000133	0.00129	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Cisplatin—esophageal cancer	0.000132	0.00129	CcSEcCtD
Mycophenolate mofetil—Renal failure—Capecitabine—esophageal cancer	0.000132	0.00129	CcSEcCtD
Mycophenolate mofetil—Myocardial infarction—Capecitabine—esophageal cancer	0.000132	0.00129	CcSEcCtD
Mycophenolate mofetil—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000132	0.00129	CcSEcCtD
Mycophenolate mofetil—Anaemia—Cisplatin—esophageal cancer	0.000132	0.00128	CcSEcCtD
Mycophenolate mofetil—Jaundice—Capecitabine—esophageal cancer	0.000131	0.00128	CcSEcCtD
Mycophenolate mofetil—Stomatitis—Capecitabine—esophageal cancer	0.000131	0.00128	CcSEcCtD
Mycophenolate mofetil—Conjunctivitis—Capecitabine—esophageal cancer	0.000131	0.00127	CcSEcCtD
Mycophenolate mofetil—Urinary tract infection—Capecitabine—esophageal cancer	0.000131	0.00127	CcSEcCtD
Mycophenolate mofetil—Osteoarthritis—Methotrexate—esophageal cancer	0.00013	0.00127	CcSEcCtD
Mycophenolate mofetil—Malaise—Cisplatin—esophageal cancer	0.000129	0.00125	CcSEcCtD
Mycophenolate mofetil—Haematuria—Capecitabine—esophageal cancer	0.000128	0.00125	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Cisplatin—esophageal cancer	0.000128	0.00124	CcSEcCtD
Mycophenolate mofetil—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000127	0.00124	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Capecitabine—esophageal cancer	0.000127	0.00124	CcSEcCtD
Mycophenolate mofetil—Agranulocytosis—Capecitabine—esophageal cancer	0.000125	0.00122	CcSEcCtD
Mycophenolate mofetil—Convulsion—Cisplatin—esophageal cancer	0.000123	0.0012	CcSEcCtD
Mycophenolate mofetil—Mood swings—Methotrexate—esophageal cancer	0.000123	0.0012	CcSEcCtD
Mycophenolate mofetil—Bradycardia—Capecitabine—esophageal cancer	0.000123	0.0012	CcSEcCtD
Mycophenolate mofetil—Myalgia—Cisplatin—esophageal cancer	0.000121	0.00118	CcSEcCtD
Mycophenolate mofetil—Haemoglobin—Capecitabine—esophageal cancer	0.000121	0.00118	CcSEcCtD
Mycophenolate mofetil—Rhinitis—Capecitabine—esophageal cancer	0.000121	0.00118	CcSEcCtD
Mycophenolate mofetil—Anxiety—Cisplatin—esophageal cancer	0.000121	0.00118	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Capecitabine—esophageal cancer	0.000121	0.00118	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Capecitabine—esophageal cancer	0.000121	0.00118	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00012	0.00118	CcSEcCtD
Mycophenolate mofetil—Hypoaesthesia—Capecitabine—esophageal cancer	0.00012	0.00117	CcSEcCtD
Mycophenolate mofetil—Liver function test abnormal—Methotrexate—esophageal cancer	0.00012	0.00117	CcSEcCtD
Mycophenolate mofetil—Discomfort—Cisplatin—esophageal cancer	0.00012	0.00117	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Capecitabine—esophageal cancer	0.00012	0.00117	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Capecitabine—esophageal cancer	0.000119	0.00116	CcSEcCtD
Mycophenolate mofetil—Oedema peripheral—Capecitabine—esophageal cancer	0.000119	0.00116	CcSEcCtD
Mycophenolate mofetil—Connective tissue disorder—Capecitabine—esophageal cancer	0.000119	0.00116	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Capecitabine—esophageal cancer	0.000118	0.00115	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Cisplatin—esophageal cancer	0.000116	0.00113	CcSEcCtD
Mycophenolate mofetil—Oedema—Cisplatin—esophageal cancer	0.000116	0.00113	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Capecitabine—esophageal cancer	0.000116	0.00113	CcSEcCtD
Mycophenolate mofetil—Infection—Cisplatin—esophageal cancer	0.000116	0.00113	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Cisplatin—esophageal cancer	0.000114	0.00111	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Cisplatin—esophageal cancer	0.000114	0.00111	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Cisplatin—esophageal cancer	0.000114	0.00111	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Cisplatin—esophageal cancer	0.000113	0.0011	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Capecitabine—esophageal cancer	0.000113	0.0011	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Capecitabine—esophageal cancer	0.000113	0.0011	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Cisplatin—esophageal cancer	0.000112	0.0011	CcSEcCtD
Mycophenolate mofetil—Asthma—Methotrexate—esophageal cancer	0.000112	0.00109	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Capecitabine—esophageal cancer	0.000112	0.00109	CcSEcCtD
Mycophenolate mofetil—Anorexia—Cisplatin—esophageal cancer	0.000111	0.00108	CcSEcCtD
Mycophenolate mofetil—Pancreatitis—Methotrexate—esophageal cancer	0.00011	0.00107	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Capecitabine—esophageal cancer	0.000109	0.00107	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Capecitabine—esophageal cancer	0.000109	0.00106	CcSEcCtD
Mycophenolate mofetil—Hypotension—Cisplatin—esophageal cancer	0.000109	0.00106	CcSEcCtD
Mycophenolate mofetil—Chills—Capecitabine—esophageal cancer	0.000108	0.00106	CcSEcCtD
Mycophenolate mofetil—Arrhythmia—Capecitabine—esophageal cancer	0.000108	0.00105	CcSEcCtD
Mycophenolate mofetil—Alopecia—Capecitabine—esophageal cancer	0.000107	0.00104	CcSEcCtD
Mycophenolate mofetil—Pancytopenia—Methotrexate—esophageal cancer	0.000107	0.00104	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000106	0.00103	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Capecitabine—esophageal cancer	0.000106	0.00103	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Capecitabine—esophageal cancer	0.000105	0.00102	CcSEcCtD
Mycophenolate mofetil—Dysuria—Methotrexate—esophageal cancer	0.000105	0.00102	CcSEcCtD
Mycophenolate mofetil—Neutropenia—Methotrexate—esophageal cancer	0.000105	0.00102	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Cisplatin—esophageal cancer	0.000104	0.00102	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Cisplatin—esophageal cancer	0.000104	0.00101	CcSEcCtD
Mycophenolate mofetil—Flatulence—Capecitabine—esophageal cancer	0.000104	0.00101	CcSEcCtD
Mycophenolate mofetil—Erectile dysfunction—Methotrexate—esophageal cancer	0.000103	0.00101	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Capecitabine—esophageal cancer	0.000103	0.001	CcSEcCtD
Mycophenolate mofetil—Back pain—Capecitabine—esophageal cancer	0.000102	0.000991	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Cisplatin—esophageal cancer	0.000101	0.000986	CcSEcCtD
Mycophenolate mofetil—Muscle spasms—Capecitabine—esophageal cancer	0.000101	0.000985	CcSEcCtD
Mycophenolate mofetil—Pneumonia—Methotrexate—esophageal cancer	0.000101	0.000982	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.0001	0.000979	CcSEcCtD
Mycophenolate mofetil—Infestation NOS—Methotrexate—esophageal cancer	0.0001	0.000976	CcSEcCtD
Mycophenolate mofetil—Infestation—Methotrexate—esophageal cancer	0.0001	0.000976	CcSEcCtD
Mycophenolate mofetil—Depression—Methotrexate—esophageal cancer	9.98e-05	0.000973	CcSEcCtD
Mycophenolate mofetil—Pain—Cisplatin—esophageal cancer	9.95e-05	0.00097	CcSEcCtD
Mycophenolate mofetil—Tremor—Capecitabine—esophageal cancer	9.84e-05	0.00096	CcSEcCtD
Mycophenolate mofetil—Renal failure—Methotrexate—esophageal cancer	9.84e-05	0.000959	CcSEcCtD
Mycophenolate mofetil—Stomatitis—Methotrexate—esophageal cancer	9.75e-05	0.000951	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Capecitabine—esophageal cancer	9.75e-05	0.000951	CcSEcCtD
Mycophenolate mofetil—Conjunctivitis—Methotrexate—esophageal cancer	9.73e-05	0.000949	CcSEcCtD
Mycophenolate mofetil—Anaemia—Capecitabine—esophageal cancer	9.71e-05	0.000947	CcSEcCtD
Mycophenolate mofetil—Sweating—Methotrexate—esophageal cancer	9.59e-05	0.000936	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Cisplatin—esophageal cancer	9.58e-05	0.000935	CcSEcCtD
Mycophenolate mofetil—Haematuria—Methotrexate—esophageal cancer	9.54e-05	0.000931	CcSEcCtD
Mycophenolate mofetil—Malaise—Capecitabine—esophageal cancer	9.47e-05	0.000924	CcSEcCtD
Mycophenolate mofetil—Hepatobiliary disease—Methotrexate—esophageal cancer	9.46e-05	0.000923	CcSEcCtD
Mycophenolate mofetil—Epistaxis—Methotrexate—esophageal cancer	9.44e-05	0.000921	CcSEcCtD
Mycophenolate mofetil—Vertigo—Capecitabine—esophageal cancer	9.44e-05	0.00092	CcSEcCtD
Mycophenolate mofetil—Syncope—Capecitabine—esophageal cancer	9.42e-05	0.000919	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Capecitabine—esophageal cancer	9.4e-05	0.000917	CcSEcCtD
Mycophenolate mofetil—ABCB1—lymph node—esophageal cancer	9.4e-05	0.00228	CbGeAlD
Mycophenolate mofetil—Agranulocytosis—Methotrexate—esophageal cancer	9.34e-05	0.000911	CcSEcCtD
Mycophenolate mofetil—Palpitations—Capecitabine—esophageal cancer	9.28e-05	0.000905	CcSEcCtD
Mycophenolate mofetil—Loss of consciousness—Capecitabine—esophageal cancer	9.23e-05	0.0009	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Cisplatin—esophageal cancer	9.19e-05	0.000897	CcSEcCtD
Mycophenolate mofetil—Cough—Capecitabine—esophageal cancer	9.17e-05	0.000894	CcSEcCtD
Mycophenolate mofetil—Hypertension—Capecitabine—esophageal cancer	9.07e-05	0.000885	CcSEcCtD
Mycophenolate mofetil—Haemoglobin—Methotrexate—esophageal cancer	9.03e-05	0.000881	CcSEcCtD
Mycophenolate mofetil—Haemorrhage—Methotrexate—esophageal cancer	8.98e-05	0.000876	CcSEcCtD
Mycophenolate mofetil—Hepatitis—Methotrexate—esophageal cancer	8.98e-05	0.000876	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Capecitabine—esophageal cancer	8.94e-05	0.000872	CcSEcCtD
Mycophenolate mofetil—Chest pain—Capecitabine—esophageal cancer	8.94e-05	0.000872	CcSEcCtD
Mycophenolate mofetil—Myalgia—Capecitabine—esophageal cancer	8.94e-05	0.000872	CcSEcCtD
Mycophenolate mofetil—Pharyngitis—Methotrexate—esophageal cancer	8.92e-05	0.00087	CcSEcCtD
Mycophenolate mofetil—Anxiety—Capecitabine—esophageal cancer	8.91e-05	0.000869	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	8.88e-05	0.000866	CcSEcCtD
Mycophenolate mofetil—Urinary tract disorder—Methotrexate—esophageal cancer	8.87e-05	0.000865	CcSEcCtD
Mycophenolate mofetil—Discomfort—Capecitabine—esophageal cancer	8.84e-05	0.000862	CcSEcCtD
Mycophenolate mofetil—Urethral disorder—Methotrexate—esophageal cancer	8.81e-05	0.000859	CcSEcCtD
Mycophenolate mofetil—Dry mouth—Capecitabine—esophageal cancer	8.75e-05	0.000853	CcSEcCtD
Mycophenolate mofetil—Visual impairment—Methotrexate—esophageal cancer	8.66e-05	0.000844	CcSEcCtD
Mycophenolate mofetil—Confusional state—Capecitabine—esophageal cancer	8.64e-05	0.000843	CcSEcCtD
Mycophenolate mofetil—Oedema—Capecitabine—esophageal cancer	8.57e-05	0.000836	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Cisplatin—esophageal cancer	8.57e-05	0.000836	CcSEcCtD
Mycophenolate mofetil—Infection—Capecitabine—esophageal cancer	8.52e-05	0.000831	CcSEcCtD
Mycophenolate mofetil—Shock—Capecitabine—esophageal cancer	8.43e-05	0.000823	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Capecitabine—esophageal cancer	8.41e-05	0.00082	CcSEcCtD
Mycophenolate mofetil—Eye disorder—Methotrexate—esophageal cancer	8.39e-05	0.000819	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Capecitabine—esophageal cancer	8.39e-05	0.000819	CcSEcCtD
Mycophenolate mofetil—Tinnitus—Methotrexate—esophageal cancer	8.38e-05	0.000817	CcSEcCtD
Mycophenolate mofetil—Tachycardia—Capecitabine—esophageal cancer	8.37e-05	0.000816	CcSEcCtD
Mycophenolate mofetil—Asthenia—Cisplatin—esophageal cancer	8.34e-05	0.000814	CcSEcCtD
Mycophenolate mofetil—Cardiac disorder—Methotrexate—esophageal cancer	8.34e-05	0.000813	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Capecitabine—esophageal cancer	8.33e-05	0.000812	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Capecitabine—esophageal cancer	8.29e-05	0.000808	CcSEcCtD
Mycophenolate mofetil—Anorexia—Capecitabine—esophageal cancer	8.17e-05	0.000797	CcSEcCtD
Mycophenolate mofetil—Angiopathy—Methotrexate—esophageal cancer	8.15e-05	0.000795	CcSEcCtD
Mycophenolate mofetil—Mediastinal disorder—Methotrexate—esophageal cancer	8.1e-05	0.00079	CcSEcCtD
Mycophenolate mofetil—Chills—Methotrexate—esophageal cancer	8.06e-05	0.000786	CcSEcCtD
Mycophenolate mofetil—Hypotension—Capecitabine—esophageal cancer	8.01e-05	0.000781	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Cisplatin—esophageal cancer	7.96e-05	0.000776	CcSEcCtD
Mycophenolate mofetil—Alopecia—Methotrexate—esophageal cancer	7.94e-05	0.000774	CcSEcCtD
Mycophenolate mofetil—Mental disorder—Methotrexate—esophageal cancer	7.87e-05	0.000768	CcSEcCtD
Mycophenolate mofetil—Malnutrition—Methotrexate—esophageal cancer	7.82e-05	0.000763	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Capecitabine—esophageal cancer	7.81e-05	0.000762	CcSEcCtD
Mycophenolate mofetil—Insomnia—Capecitabine—esophageal cancer	7.75e-05	0.000756	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Capecitabine—esophageal cancer	7.7e-05	0.000751	CcSEcCtD
Mycophenolate mofetil—Dysgeusia—Methotrexate—esophageal cancer	7.66e-05	0.000747	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Capecitabine—esophageal cancer	7.64e-05	0.000745	CcSEcCtD
Mycophenolate mofetil—Back pain—Methotrexate—esophageal cancer	7.56e-05	0.000738	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Capecitabine—esophageal cancer	7.55e-05	0.000736	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Capecitabine—esophageal cancer	7.45e-05	0.000727	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Capecitabine—esophageal cancer	7.4e-05	0.000722	CcSEcCtD
Mycophenolate mofetil—Vomiting—Cisplatin—esophageal cancer	7.39e-05	0.000721	CcSEcCtD
Mycophenolate mofetil—Rash—Cisplatin—esophageal cancer	7.33e-05	0.000715	CcSEcCtD
Mycophenolate mofetil—Pain—Capecitabine—esophageal cancer	7.33e-05	0.000715	CcSEcCtD
Mycophenolate mofetil—Constipation—Capecitabine—esophageal cancer	7.33e-05	0.000715	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Cisplatin—esophageal cancer	7.33e-05	0.000715	CcSEcCtD
Mycophenolate mofetil—Ill-defined disorder—Methotrexate—esophageal cancer	7.26e-05	0.000708	CcSEcCtD
Mycophenolate mofetil—Anaemia—Methotrexate—esophageal cancer	7.23e-05	0.000705	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Capecitabine—esophageal cancer	7.06e-05	0.000689	CcSEcCtD
Mycophenolate mofetil—Malaise—Methotrexate—esophageal cancer	7.05e-05	0.000688	CcSEcCtD
Mycophenolate mofetil—Vertigo—Methotrexate—esophageal cancer	7.03e-05	0.000685	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Capecitabine—esophageal cancer	7.01e-05	0.000684	CcSEcCtD
Mycophenolate mofetil—Leukopenia—Methotrexate—esophageal cancer	7e-05	0.000683	CcSEcCtD
Mycophenolate mofetil—Nausea—Cisplatin—esophageal cancer	6.91e-05	0.000674	CcSEcCtD
Mycophenolate mofetil—Cough—Methotrexate—esophageal cancer	6.82e-05	0.000666	CcSEcCtD
Mycophenolate mofetil—Urticaria—Capecitabine—esophageal cancer	6.81e-05	0.000664	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Capecitabine—esophageal cancer	6.78e-05	0.000661	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Capecitabine—esophageal cancer	6.78e-05	0.000661	CcSEcCtD
Mycophenolate mofetil—Convulsion—Methotrexate—esophageal cancer	6.78e-05	0.000661	CcSEcCtD
Mycophenolate mofetil—Myalgia—Methotrexate—esophageal cancer	6.66e-05	0.000649	CcSEcCtD
Mycophenolate mofetil—Arthralgia—Methotrexate—esophageal cancer	6.66e-05	0.000649	CcSEcCtD
Mycophenolate mofetil—Chest pain—Methotrexate—esophageal cancer	6.66e-05	0.000649	CcSEcCtD
Mycophenolate mofetil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	6.61e-05	0.000645	CcSEcCtD
Mycophenolate mofetil—Discomfort—Methotrexate—esophageal cancer	6.58e-05	0.000642	CcSEcCtD
Mycophenolate mofetil—Confusional state—Methotrexate—esophageal cancer	6.43e-05	0.000628	CcSEcCtD
Mycophenolate mofetil—Anaphylactic shock—Methotrexate—esophageal cancer	6.38e-05	0.000622	CcSEcCtD
Mycophenolate mofetil—Infection—Methotrexate—esophageal cancer	6.34e-05	0.000618	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Capecitabine—esophageal cancer	6.32e-05	0.000616	CcSEcCtD
Mycophenolate mofetil—Nervous system disorder—Methotrexate—esophageal cancer	6.26e-05	0.00061	CcSEcCtD
Mycophenolate mofetil—Thrombocytopenia—Methotrexate—esophageal cancer	6.25e-05	0.000609	CcSEcCtD
Mycophenolate mofetil—Skin disorder—Methotrexate—esophageal cancer	6.2e-05	0.000605	CcSEcCtD
Mycophenolate mofetil—Hyperhidrosis—Methotrexate—esophageal cancer	6.17e-05	0.000602	CcSEcCtD
Mycophenolate mofetil—Asthenia—Capecitabine—esophageal cancer	6.15e-05	0.0006	CcSEcCtD
Mycophenolate mofetil—Anorexia—Methotrexate—esophageal cancer	6.08e-05	0.000593	CcSEcCtD
Mycophenolate mofetil—Pruritus—Capecitabine—esophageal cancer	6.07e-05	0.000592	CcSEcCtD
Mycophenolate mofetil—Hypotension—Methotrexate—esophageal cancer	5.96e-05	0.000582	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Capecitabine—esophageal cancer	5.87e-05	0.000572	CcSEcCtD
Mycophenolate mofetil—Musculoskeletal discomfort—Methotrexate—esophageal cancer	5.81e-05	0.000567	CcSEcCtD
Mycophenolate mofetil—Insomnia—Methotrexate—esophageal cancer	5.77e-05	0.000563	CcSEcCtD
Mycophenolate mofetil—Paraesthesia—Methotrexate—esophageal cancer	5.73e-05	0.000559	CcSEcCtD
Mycophenolate mofetil—Dyspnoea—Methotrexate—esophageal cancer	5.69e-05	0.000555	CcSEcCtD
Mycophenolate mofetil—Somnolence—Methotrexate—esophageal cancer	5.67e-05	0.000553	CcSEcCtD
Mycophenolate mofetil—Dizziness—Capecitabine—esophageal cancer	5.67e-05	0.000553	CcSEcCtD
Mycophenolate mofetil—Dyspepsia—Methotrexate—esophageal cancer	5.62e-05	0.000548	CcSEcCtD
Mycophenolate mofetil—Decreased appetite—Methotrexate—esophageal cancer	5.55e-05	0.000541	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal disorder—Methotrexate—esophageal cancer	5.51e-05	0.000537	CcSEcCtD
Mycophenolate mofetil—Pain—Methotrexate—esophageal cancer	5.46e-05	0.000532	CcSEcCtD
Mycophenolate mofetil—Vomiting—Capecitabine—esophageal cancer	5.45e-05	0.000532	CcSEcCtD
Mycophenolate mofetil—Rash—Capecitabine—esophageal cancer	5.41e-05	0.000527	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Capecitabine—esophageal cancer	5.4e-05	0.000527	CcSEcCtD
Mycophenolate mofetil—Headache—Capecitabine—esophageal cancer	5.37e-05	0.000524	CcSEcCtD
Mycophenolate mofetil—Feeling abnormal—Methotrexate—esophageal cancer	5.26e-05	0.000513	CcSEcCtD
Mycophenolate mofetil—Gastrointestinal pain—Methotrexate—esophageal cancer	5.22e-05	0.000509	CcSEcCtD
Mycophenolate mofetil—Nausea—Capecitabine—esophageal cancer	5.09e-05	0.000497	CcSEcCtD
Mycophenolate mofetil—Urticaria—Methotrexate—esophageal cancer	5.07e-05	0.000494	CcSEcCtD
Mycophenolate mofetil—Abdominal pain—Methotrexate—esophageal cancer	5.05e-05	0.000492	CcSEcCtD
Mycophenolate mofetil—Body temperature increased—Methotrexate—esophageal cancer	5.05e-05	0.000492	CcSEcCtD
Mycophenolate mofetil—Hypersensitivity—Methotrexate—esophageal cancer	4.7e-05	0.000459	CcSEcCtD
Mycophenolate mofetil—Asthenia—Methotrexate—esophageal cancer	4.58e-05	0.000447	CcSEcCtD
Mycophenolate mofetil—Pruritus—Methotrexate—esophageal cancer	4.52e-05	0.00044	CcSEcCtD
Mycophenolate mofetil—Diarrhoea—Methotrexate—esophageal cancer	4.37e-05	0.000426	CcSEcCtD
Mycophenolate mofetil—Dizziness—Methotrexate—esophageal cancer	4.22e-05	0.000412	CcSEcCtD
Mycophenolate mofetil—Vomiting—Methotrexate—esophageal cancer	4.06e-05	0.000396	CcSEcCtD
Mycophenolate mofetil—Rash—Methotrexate—esophageal cancer	4.02e-05	0.000392	CcSEcCtD
Mycophenolate mofetil—Dermatitis—Methotrexate—esophageal cancer	4.02e-05	0.000392	CcSEcCtD
Mycophenolate mofetil—Headache—Methotrexate—esophageal cancer	4e-05	0.00039	CcSEcCtD
Mycophenolate mofetil—Nausea—Methotrexate—esophageal cancer	3.79e-05	0.00037	CcSEcCtD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	9.44e-06	8.14e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PLCE1—esophageal cancer	9.37e-06	8.08e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ADH7—esophageal cancer	9.37e-06	8.08e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—ABCB1—esophageal cancer	9.36e-06	8.07e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—ALDH2—esophageal cancer	9.33e-06	8.04e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PLCE1—esophageal cancer	9.32e-06	8.03e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ADH7—esophageal cancer	9.32e-06	8.03e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	9.26e-06	7.99e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	9.26e-06	7.99e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—NOS3—esophageal cancer	9.26e-06	7.98e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	9.21e-06	7.94e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A7—Metabolism—PIK3CA—esophageal cancer	9.18e-06	7.92e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—ABL1—esophageal cancer	9.15e-06	7.89e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—TYMP—esophageal cancer	9.07e-06	7.82e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—ENO1—esophageal cancer	8.98e-06	7.74e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PTGS1—esophageal cancer	8.98e-06	7.74e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	8.97e-06	7.74e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—GSTT1—esophageal cancer	8.87e-06	7.65e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PSME2—esophageal cancer	8.85e-06	7.63e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PSME1—esophageal cancer	8.85e-06	7.63e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CYP26A1—esophageal cancer	8.82e-06	7.6e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—HMOX1—esophageal cancer	8.8e-06	7.59e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CA2—esophageal cancer	8.78e-06	7.57e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CYP2A6—esophageal cancer	8.77e-06	7.56e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ALOX15—esophageal cancer	8.59e-06	7.41e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—PTGS2—esophageal cancer	8.47e-06	7.3e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—ABCB1—esophageal cancer	8.44e-06	7.28e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	8.43e-06	7.27e-05	CbGpPWpGaD
Mycophenolate mofetil—IMPDH1—Metabolism—PIK3CA—esophageal cancer	8.4e-06	7.24e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	8.37e-06	7.22e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CYP1B1—esophageal cancer	8.33e-06	7.18e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CYP1B1—esophageal cancer	8.33e-06	7.18e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—ENO1—esophageal cancer	8.31e-06	7.17e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PTGS1—esophageal cancer	8.31e-06	7.17e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	8.31e-06	7.16e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ADH1B—esophageal cancer	8.22e-06	7.08e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—TPI1—esophageal cancer	8.2e-06	7.07e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GSTO1—esophageal cancer	8.2e-06	7.07e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PSME2—esophageal cancer	8.19e-06	7.06e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PSME1—esophageal cancer	8.19e-06	7.06e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ADH1B—esophageal cancer	8.17e-06	7.04e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PLCE1—esophageal cancer	8.16e-06	7.04e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ADH7—esophageal cancer	8.16e-06	7.04e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	8.1e-06	6.98e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—HMOX1—esophageal cancer	7.99e-06	6.89e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ALDOB—esophageal cancer	7.86e-06	6.78e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—TYMP—esophageal cancer	7.85e-06	6.77e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CYP19A1—esophageal cancer	7.83e-06	6.75e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CYP19A1—esophageal cancer	7.83e-06	6.75e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—TYMP—esophageal cancer	7.81e-06	6.73e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	7.73e-06	6.66e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	7.7e-06	6.64e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—ABCB1—esophageal cancer	7.67e-06	6.61e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP26A1—esophageal cancer	7.64e-06	6.59e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—CYP1B1—esophageal cancer	7.64e-06	6.58e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP26A1—esophageal cancer	7.6e-06	6.55e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GAPDH—esophageal cancer	7.57e-06	6.52e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CRABP1—esophageal cancer	7.5e-06	6.47e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ALOX15—esophageal cancer	7.44e-06	6.42e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ALOX15—esophageal cancer	7.4e-06	6.38e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—CYP19A1—esophageal cancer	7.18e-06	6.19e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ADH1B—esophageal cancer	7.16e-06	6.17e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—HMOX1—esophageal cancer	7.15e-06	6.16e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—HMOX1—esophageal cancer	7.15e-06	6.16e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A8—Metabolism—PIK3CA—esophageal cancer	7.14e-06	6.16e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GNG7—esophageal cancer	7.13e-06	6.15e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GSTO1—esophageal cancer	7.1e-06	6.12e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—TPI1—esophageal cancer	7.1e-06	6.12e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	7.08e-06	6.1e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CYP1B1—esophageal cancer	7.07e-06	6.1e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GSTO1—esophageal cancer	7.06e-06	6.09e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—TPI1—esophageal cancer	7.06e-06	6.09e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—EP300—esophageal cancer	7.04e-06	6.07e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.01e-06	6.05e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	7e-06	6.04e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SLC52A3—esophageal cancer	6.96e-06	6e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—BLVRB—esophageal cancer	6.96e-06	6e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—ABCB1—esophageal cancer	6.86e-06	5.92e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—ABCB1—esophageal cancer	6.86e-06	5.92e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—TYMP—esophageal cancer	6.84e-06	5.9e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ALDOB—esophageal cancer	6.81e-06	5.87e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ALDOB—esophageal cancer	6.77e-06	5.84e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	6.71e-06	5.79e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ALDH2—esophageal cancer	6.68e-06	5.76e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP26A1—esophageal cancer	6.66e-06	5.74e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CYP19A1—esophageal cancer	6.65e-06	5.73e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—NOS2—esophageal cancer	6.59e-06	5.69e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	6.57e-06	5.66e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GAPDH—esophageal cancer	6.55e-06	5.65e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—HMOX1—esophageal cancer	6.55e-06	5.65e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GAPDH—esophageal cancer	6.52e-06	5.62e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CRABP1—esophageal cancer	6.5e-06	5.6e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ALOX15—esophageal cancer	6.49e-06	5.59e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CRABP1—esophageal cancer	6.46e-06	5.57e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	6.43e-06	5.54e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—GSTT1—esophageal cancer	6.36e-06	5.48e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—ABCB1—esophageal cancer	6.29e-06	5.42e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CYP2A6—esophageal cancer	6.28e-06	5.42e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—CREBBP—esophageal cancer	6.25e-06	5.39e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GSTO1—esophageal cancer	6.19e-06	5.33e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—TPI1—esophageal cancer	6.19e-06	5.33e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GNG7—esophageal cancer	6.18e-06	5.33e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GNG7—esophageal cancer	6.14e-06	5.3e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—HMOX1—esophageal cancer	6.07e-06	5.23e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ENO1—esophageal cancer	5.96e-06	5.14e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PTGS1—esophageal cancer	5.96e-06	5.14e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ALDOB—esophageal cancer	5.93e-06	5.11e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—CREBBP—esophageal cancer	5.92e-06	5.11e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CA1—esophageal cancer	5.92e-06	5.1e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—SLC10A2—esophageal cancer	5.92e-06	5.1e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PSME2—esophageal cancer	5.87e-06	5.06e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PSME1—esophageal cancer	5.87e-06	5.06e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—ABCB1—esophageal cancer	5.82e-06	5.02e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ALDH2—esophageal cancer	5.79e-06	4.99e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Platelet activation, signaling and aggregation—PIK3CA—esophageal cancer	5.79e-06	4.99e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ALDH2—esophageal cancer	5.76e-06	4.96e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GAPDH—esophageal cancer	5.71e-06	4.92e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	5.7e-06	4.91e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CRABP1—esophageal cancer	5.66e-06	4.88e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—CREBBP—esophageal cancer	5.64e-06	4.87e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—NOS3—esophageal cancer	5.6e-06	4.83e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	5.51e-06	4.75e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—GSTT1—esophageal cancer	5.51e-06	4.75e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—GSTT1—esophageal cancer	5.48e-06	4.72e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP2A6—esophageal cancer	5.44e-06	4.69e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	5.42e-06	4.67e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP2A6—esophageal cancer	5.41e-06	4.67e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CA2—esophageal cancer	5.41e-06	4.66e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	5.39e-06	4.65e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GNG7—esophageal cancer	5.38e-06	4.64e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—NOS3—esophageal cancer	5.3e-06	4.57e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A6—Metabolism—PIK3CA—esophageal cancer	5.21e-06	4.49e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.19e-06	4.47e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ENO1—esophageal cancer	5.16e-06	4.45e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PTGS1—esophageal cancer	5.16e-06	4.45e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PTGS1—esophageal cancer	5.13e-06	4.42e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ENO1—esophageal cancer	5.13e-06	4.42e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Transmembrane transport of small molecules—CREBBP—esophageal cancer	5.13e-06	4.42e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PTGS2—esophageal cancer	5.12e-06	4.42e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PSME1—esophageal cancer	5.08e-06	4.38e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PSME2—esophageal cancer	5.08e-06	4.38e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CYP1B1—esophageal cancer	5.07e-06	4.37e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PSME2—esophageal cancer	5.06e-06	4.36e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PSME1—esophageal cancer	5.06e-06	4.36e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—NOS3—esophageal cancer	5.05e-06	4.36e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ALDH2—esophageal cancer	5.04e-06	4.35e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ADH7—esophageal cancer	5.03e-06	4.34e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PLCE1—esophageal cancer	5.03e-06	4.34e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—GSTT1—esophageal cancer	4.8e-06	4.14e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CYP19A1—esophageal cancer	4.76e-06	4.11e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	4.75e-06	4.1e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP2A6—esophageal cancer	4.74e-06	4.09e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PTGS2—esophageal cancer	4.62e-06	3.98e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—CREBBP—esophageal cancer	4.59e-06	3.95e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—CREBBP—esophageal cancer	4.59e-06	3.95e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PTGS1—esophageal cancer	4.5e-06	3.88e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—ENO1—esophageal cancer	4.5e-06	3.88e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	4.49e-06	3.87e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.44e-06	3.83e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PSME1—esophageal cancer	4.43e-06	3.82e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PSME2—esophageal cancer	4.43e-06	3.82e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	4.41e-06	3.81e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ADH1B—esophageal cancer	4.41e-06	3.8e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP1B1—esophageal cancer	4.39e-06	3.78e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP1B1—esophageal cancer	4.36e-06	3.76e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—HMOX1—esophageal cancer	4.35e-06	3.75e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—EP300—esophageal cancer	4.26e-06	3.67e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—TYMP—esophageal cancer	4.21e-06	3.63e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—CREBBP—esophageal cancer	4.2e-06	3.62e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—ABCB1—esophageal cancer	4.17e-06	3.6e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CYP19A1—esophageal cancer	4.13e-06	3.56e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—NOS3—esophageal cancer	4.11e-06	3.54e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—NOS3—esophageal cancer	4.11e-06	3.54e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CYP19A1—esophageal cancer	4.1e-06	3.54e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP26A1—esophageal cancer	4.1e-06	3.54e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—EP300—esophageal cancer	4.03e-06	3.48e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ALOX15—esophageal cancer	4e-06	3.45e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—CREBBP—esophageal cancer	3.89e-06	3.35e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—EP300—esophageal cancer	3.84e-06	3.31e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP1B1—esophageal cancer	3.82e-06	3.3e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—TPI1—esophageal cancer	3.81e-06	3.29e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTO1—esophageal cancer	3.81e-06	3.29e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—HMOX1—esophageal cancer	3.76e-06	3.25e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—NOS3—esophageal cancer	3.76e-06	3.24e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PTGS2—esophageal cancer	3.76e-06	3.24e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PTGS2—esophageal cancer	3.76e-06	3.24e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—HMOX1—esophageal cancer	3.74e-06	3.23e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.69e-06	3.18e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	3.67e-06	3.17e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ALDOB—esophageal cancer	3.65e-06	3.15e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—ABCB1—esophageal cancer	3.61e-06	3.12e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CYP19A1—esophageal cancer	3.59e-06	3.1e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—ABCB1—esophageal cancer	3.59e-06	3.1e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GAPDH—esophageal cancer	3.52e-06	3.03e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CRABP1—esophageal cancer	3.49e-06	3.01e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—NOS3—esophageal cancer	3.48e-06	3e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PTGS2—esophageal cancer	3.44e-06	2.97e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GNG7—esophageal cancer	3.32e-06	2.86e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—HMOX1—esophageal cancer	3.28e-06	2.83e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PTGS2—esophageal cancer	3.19e-06	2.75e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B3—Metabolism—PIK3CA—esophageal cancer	3.15e-06	2.72e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—EP300—esophageal cancer	3.12e-06	2.69e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—EP300—esophageal cancer	3.12e-06	2.69e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ALDH2—esophageal cancer	3.11e-06	2.68e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—PIK3CA—esophageal cancer	2.98e-06	2.57e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—GSTT1—esophageal cancer	2.96e-06	2.55e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP2A6—esophageal cancer	2.92e-06	2.52e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Hemostasis—TP53—esophageal cancer	2.89e-06	2.49e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—EP300—esophageal cancer	2.86e-06	2.47e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT2B7—Metabolism—PIK3CA—esophageal cancer	2.84e-06	2.45e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—CREBBP—esophageal cancer	2.79e-06	2.4e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ENO1—esophageal cancer	2.77e-06	2.39e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PTGS1—esophageal cancer	2.77e-06	2.39e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.73e-06	2.36e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PSME2—esophageal cancer	2.73e-06	2.35e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PSME1—esophageal cancer	2.73e-06	2.35e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.72e-06	2.34e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—EP300—esophageal cancer	2.65e-06	2.28e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—NOS3—esophageal cancer	2.5e-06	2.15e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—CREBBP—esophageal cancer	2.41e-06	2.08e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—CREBBP—esophageal cancer	2.4e-06	2.07e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP1B1—esophageal cancer	2.35e-06	2.03e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A1—Metabolism—PIK3CA—esophageal cancer	2.31e-06	1.99e-05	CbGpPWpGaD
Mycophenolate mofetil—UGT1A9—Metabolism—PIK3CA—esophageal cancer	2.31e-06	1.99e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PTGS2—esophageal cancer	2.28e-06	1.97e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CYP19A1—esophageal cancer	2.21e-06	1.91e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—NOS3—esophageal cancer	2.16e-06	1.86e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—NOS3—esophageal cancer	2.15e-06	1.85e-05	CbGpPWpGaD
Mycophenolate mofetil—SLCO1B1—Metabolism—PIK3CA—esophageal cancer	2.12e-06	1.83e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—CREBBP—esophageal cancer	2.1e-06	1.81e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—HMOX1—esophageal cancer	2.02e-06	1.74e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PTGS2—esophageal cancer	1.98e-06	1.7e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PTGS2—esophageal cancer	1.97e-06	1.7e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCG2—Metabolism—PIK3CA—esophageal cancer	1.96e-06	1.69e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.94e-06	1.67e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—EP300—esophageal cancer	1.9e-06	1.64e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—NOS3—esophageal cancer	1.88e-06	1.62e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PTGS2—esophageal cancer	1.72e-06	1.49e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—EP300—esophageal cancer	1.64e-06	1.42e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—EP300—esophageal cancer	1.64e-06	1.41e-05	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—EP300—esophageal cancer	1.43e-06	1.24e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A5—Metabolism—PIK3CA—esophageal cancer	1.4e-06	1.21e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—CREBBP—esophageal cancer	1.3e-06	1.12e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP2C8—Metabolism—PIK3CA—esophageal cancer	1.22e-06	1.05e-05	CbGpPWpGaD
Mycophenolate mofetil—ALB—Metabolism—PIK3CA—esophageal cancer	1.21e-06	1.04e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—NOS3—esophageal cancer	1.16e-06	1e-05	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PTGS2—esophageal cancer	1.06e-06	9.15e-06	CbGpPWpGaD
Mycophenolate mofetil—ABCB1—Metabolism—PIK3CA—esophageal cancer	1.06e-06	9.14e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—EP300—esophageal cancer	8.83e-07	7.61e-06	CbGpPWpGaD
Mycophenolate mofetil—CYP3A4—Metabolism—PIK3CA—esophageal cancer	6.53e-07	5.63e-06	CbGpPWpGaD
